Over the last two decades, the evolution of sophisticated technologies have enabled drug developers to harness antibodies' exquisite target-binding properties, turning them into a safe and reliable therapeutic modality. There are already more than 80 approved antibody drugs on the market, including several blockbusters for treating cancer and inflammatory conditions.
Natural immune systems are a rich source of antibody-producing cells that protect us from environmental hazards. This immune landscape is incredibly vast and complex; it has been estimated that humans make around ten billion different antibodies, each with the ability to bind to a specific antigen on a disease-causing agent.
